Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis
OE Çınar, B Sayınalp, EA Karakulak, AA Karataş… - … and Apheresis Science, 2020 - Elsevier
During the ongoing COVID-19 pandemic due to the SARS-CoV-2 virus of which evidence-
based medical paradigms cannot be easily applied; difficult clinical decisions shall be …
based medical paradigms cannot be easily applied; difficult clinical decisions shall be …
[HTML][HTML] COVID-19 convalescent plasma transfusion
DM Langhi Junior, GCD Santis… - … , transfusion and cell …, 2020 - SciELO Brasil
The pandemic caused by the novel coronavirus, called SARS-CoV-2, affected more than
one million people around the world. The COVID-19, the acronym derived from the …
one million people around the world. The COVID-19, the acronym derived from the …
El plasma de convalecientes como un tratamiento potencial en pacientes con COVID-19
E de la Caridad Rodríguez-Venegas… - Revista Cubana de …, 2021 - revibiomedica.sld.cu
Objetivo: Realizar una revisión del empleo del plasma de convalecientes como alternativa
terapéutica a la COVID-19. Desarrollo: Se empleó la estrategia de búsqueda del tema; …
terapéutica a la COVID-19. Desarrollo: Se empleó la estrategia de búsqueda del tema; …